Free Trial

Design Therapeutics (DSGN) Insider Trading & Ownership

Design Therapeutics logo
$5.48 0.00 (0.00%)
(As of 11/20/2024 ET)

Design Therapeutics (NASDAQ:DSGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
31.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$99,750.38
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$3.46 M
Get DSGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DSGN Insider Buying and Selling by Quarter

Design Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2024Arsani WilliamDirectorSell814,874$4.25$3,463,214.50  
3/25/2024John P SchmidDirectorBuy17,809$3.74$66,605.66  
3/22/2024John P SchmidDirectorBuy9,156$3.62$33,144.72  
(Data available from 1/1/2013 forward)

DSGN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Design Therapeutics includes Arsani William, Deepa Prasad, Joao Md Siffert, John P Schmid, Rodney W Lappe, Simeon George, Sr One Capital Fund I Aggregat, and Stella Xu. Learn more on insiders at DSGN.

31.20% of Design Therapeutics stock is owned by insiders. Learn more on DSGN's insider holdings.

The following insiders have purchased DSGN shares in the last 24 months: Deepa Prasad ($27,720.00), Joao Md Siffert ($9,740.50), John P Schmid ($99,750.38), Rodney W Lappe ($168,750.00), Simeon George ($7,246,800.00), and Sr One Capital Fund I Aggregat ($325,600.00).

Insiders have purchased a total of 976,115 DSGN shares in the last 24 months for a total of $7,878,360.88 bought.

The following insider sold DSGN shares in the last 24 months: Arsani William ($3,463,214.50).

Insiders have sold a total of 814,874 Design Therapeutics shares in the last 24 months for a total of $3,463,214.50 sold.

Design Therapeutics Key Executives

  • Mr. Pratik Shah Ph.D. (Age 54)
    Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
    Compensation: $704.1k
  • Dr. Sean Jeffries Ph.D. (Age 44)
    Chief Operating Officer
    Compensation: $554.01k
  • Dr. Aseem Z. Ansari Ph.D.
    Co-Founder & Scientific Advisor
  • Ms. Julie D. Burgess CPA
    Chief Accounting Officer
  • Dr. Jae B. Kim FACC (Age 54)
    M.D., Chief Medical Officer
  • Ms. Dawn Giangiulio
    Controller


This page (NASDAQ:DSGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners